319
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Chemotherapy-induced nausea and vomiting and antiemetic prophylaxis with palonosetron versus other 5-HT3 receptor antagonists in patients with cancer treated with low emetogenic chemotherapy in a hospital outpatient setting in the United States

, , , , &
Pages 1613-1622 | Accepted 08 Jun 2011, Published online: 22 Jun 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (6)

Désirée Louise Dräger. (2017) Einsatz von Cannabinoiden bei chemotherapieinduzierter Übelkeit und ErbrechenUse of cannabinoids for chemotherapy-induced nausea and vomiting. Der Urologe 57:1, pages 54-58.
Crossref
Toshinobu Hayashi, Mototsugu Shimokawa, Takanori Miyoshi, Yoko Toriyama, Chiaki Yokota, Jun Taniguchi, Kiyonori Hanada, Kyouichi Tsumagari, Noriko Okubo, Yoshimichi Koutake, Kohei Sakata, Yosei Kawamata, Takashi Goto, Yasufumi Tsurusaki & Makiko Koyabu. (2017) A prospective, observational, multicenter study on risk factors and prophylaxis for low emetic risk chemotherapy-induced nausea and vomiting. Supportive Care in Cancer 25:9, pages 2707-2714.
Crossref
Ian Olver, Christina H. Ruhlmann, Franziska Jahn, Lee Schwartzberg, Bernardo Rapoport, Cynthia N. Rittenberg & Rebecca Clark-Snow. (2016) 2016 Updated MASCC/ESMO Consensus Recommendations: Controlling nausea and vomiting with chemotherapy of low or minimal emetic potential. Supportive Care in Cancer 25:1, pages 297-301.
Crossref
Sierra Vig, Laurel Seibert & Myke R. Green. (2013) Olanzapine is effective for refractory chemotherapy-induced nausea and vomiting irrespective of chemotherapy emetogenicity. Journal of Cancer Research and Clinical Oncology 140:1, pages 77-82.
Crossref
Y. JIN, W. SUN, D. GU, J. YANG, Z. XU & J. CHEN. (2013) Comparative efficacy and safety of palonosetron with the first 5-HT3 receptor antagonists for the chemotherapy-induced nausea and vomiting: a meta-analysis. European Journal of Cancer Care 22:1, pages 41-50.
Crossref
. (2012) Current World Literature. Current Opinion in Oncology 24:4, pages 454-460.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.